Beximco Pharmaceuticals (LSE:BXP) Cash Flow from Operations : £26.1 Mil (TTM As of Mar. 2024)

Beximco Pharmaceuticals Cash Flow from Operations Chart

Beximco Pharmaceuticals Annual Data
	Trend	Dec13	Dec14	Dec15	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23
Cash Flow from Operations		Get a 7-Day Free Trial					19.80	37.08	40.30	34.89	40.71

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Cash Flow from Operations	Get a 7-Day Free Trial															11.32	12.94	11.87	-	14.26

Beximco Pharmaceuticals Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Beximco Pharmaceuticals's Cash Flow from Operations for the fiscal year that ended in Jun. 2023 is calculated as:

Beximco Pharmaceuticals's Cash Flow from Operations for the quarter that ended in Mar. 2024 is:

Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £26.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals  (LSE:BXP) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Beximco Pharmaceuticals's cash receipts from operating activities for the three months ended in Mar. 2024 was £73.7 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £-54.0 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £0.0 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £0.0 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £-1.9 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £0.0 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Beximco Pharmaceuticals's cash payments for the three months ended in Mar. 2024 was £-3.5 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Beximco Pharmaceuticals's cash flow from others for the three months ended in Mar. 2024 was £0.0 Mil.

Beximco Pharmaceuticals Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (LSE:BXP) Business Description